Division of Comparative Medicine, Massachusetts Institute of Technologygrid.116068.8, Cambridge, Massachusetts, USA.
Division of Gastroenterology, Vanderbilt University Medical Centergrid.412807.8, Nashville, Tennessee, USA.
mSphere. 2022 Feb 23;7(1):e0077221. doi: 10.1128/msphere.00772-21. Epub 2022 Feb 9.
In populations with similar prevalence of Helicobacter pylori infection, cancer risk can vary dramatically. Changes in composition or structure of bacterial communities in the stomach, either at the time of exposure or over the course of H. pylori infection, may contribute to gastric pathology. In this study, a population of 37 patients from the low-gastric-cancer-risk (LGCR) region of Tumaco, Colombia, and the high-gastric-cancer-risk (HGCR) region of Túquerres, Colombia, were recruited for gastric endoscopy. Antral biopsy specimens were processed for histology and bacterial isolation. Fifty-nine distinct species among 26 genera were isolated by aerobic, anaerobic, and microaerobic culture and confirmed by 16S rRNA analysis. Urease-positive Staphylococcus epidermidis and Streptococcus salivarius were frequently isolated from gastric biopsy specimens. We asked whether coinfection of H. pylori with urease-positive and/or S. epidermidis had a demonstrable effect on H. pyloriinduced gastritis in the germfree (GF) INS-GAS mouse model. Coinfections with and/or S. epidermidis did not affect gastric H. pylori colonization. At 5 months postinfection, GF INS-GAS mice coinfected with H. pylori and had statistically higher pathological scores in the stomachs than mice infected with H. pylori only or H. pylori with S. epidermidis ( < 0.05). S. epidermidis coinfection with H. pylori did not significantly change stomach pathology, but levels of the proinflammatory cytokine genes , , and were significantly lower than in H. pylori-monoinfected mice. This study demonstrates that non-H. pylori urease-positive bacteria may play a role in the severity of H. pyloriinduced gastric cancer in humans. Chronic infection with H. pylori is the main cause of gastric cancer, which is a global health problem. In two Colombian populations with high levels of H. pylori prevalence, the regional gastric cancer rates are considerably different. Host genetic background, H. pylori biotype, environmental toxins, and dietary choices are among the known risk factors for stomach cancer. The potential role of non-H. pylori gastric microbiota in gastric carcinogenesis is being increasingly recognized. In this study, we isolated 59 bacterial species from 37 stomach biopsy samples of Colombian patients from both low-gastric-cancer-risk and high-gastric-cancer-risk regions. Urease-positive S. epidermidis and commonly cultured from the stomachs, along with H. pylori, were inoculated into germfree INS-GAS mice. coinfection with H. pylori induced significantly higher gastric pathology than in H. pylori-monoinfected mice, whereas S. epidermidis coinfection caused significantly lower H. pylori-induced proinflammatory cytokine responses than in H. pylori-monoinfected mice. This study reinforces the argument that the non-H. pylori stomach microflora play a role in the severity of H. pylori-induced gastric cancer.
在幽门螺杆菌感染患病率相似的人群中,癌症风险可能存在显著差异。胃内细菌群落组成或结构的变化,无论是在暴露时还是在幽门螺杆菌感染过程中发生的变化,都可能导致胃部病理变化。在这项研究中,从哥伦比亚图马科的低胃癌风险(LGCR)地区和哥伦比亚图奎雷斯的高胃癌风险(HGCR)地区招募了 37 名患者进行胃镜检查。对胃活检标本进行组织学和细菌分离处理。通过需氧、厌氧和微需氧培养分离出 26 个属中的 59 个不同种,并通过 16S rRNA 分析进行确认。从胃活检标本中经常分离出产脲酶的表皮葡萄球菌和唾液链球菌。我们想知道幽门螺杆菌与产脲酶的 和/或表皮葡萄球菌的合并感染是否对无菌(GF)INS-GAS 小鼠模型中的幽门螺杆菌诱导的胃炎有明显影响。 和/或表皮葡萄球菌的合并感染并未影响胃内幽门螺杆菌定植。在感染后 5 个月,与仅感染幽门螺杆菌或感染幽门螺杆菌加表皮葡萄球菌的小鼠相比,感染幽门螺杆菌加 的 GF INS-GAS 小鼠的胃内病理学评分显著升高(<0.05)。表皮葡萄球菌与幽门螺杆菌的合并感染并未显著改变胃的病理,但促炎细胞因子基因 、 和 的水平明显低于幽门螺杆菌单感染的小鼠。这项研究表明,非幽门螺杆菌产脲酶细菌可能在人类中幽门螺杆菌诱导的胃癌的严重程度中起作用。 慢性幽门螺杆菌感染是胃癌的主要原因,这是一个全球性的健康问题。在两个哥伦比亚人群中,幽门螺杆菌的患病率很高,但胃癌的区域性发病率却有很大的不同。宿主遗传背景、幽门螺杆菌生物型、环境毒素和饮食选择是已知的胃癌危险因素。非幽门螺杆菌胃微生物群在胃癌发生中的潜在作用正日益受到关注。在这项研究中,我们从哥伦比亚低胃癌风险和高胃癌风险地区的 37 名患者的胃活检样本中分离出 59 种细菌。从胃中常培养出产脲酶的表皮葡萄球菌和 ,以及幽门螺杆菌,将其接种到无菌 INS-GAS 小鼠体内。 与幽门螺杆菌的合并感染引起的胃病理明显高于幽门螺杆菌单感染的小鼠,而表皮葡萄球菌的合并感染引起的幽门螺杆菌诱导的促炎细胞因子反应明显低于幽门螺杆菌单感染的小鼠。这项研究再次证实,非幽门螺杆菌胃微生物群在幽门螺杆菌诱导的胃癌严重程度中起作用。